You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞信窝轮》中移偏软药股强势,留意中移购11976、石药购11412
阿思达克 12-23 13:28

落後股中移动(0941)上周五突受追捧後,不过周一无以为继,股价及後轻微偏软。中移动上月上客量按月升逾89%,向上观望突破65元的机会,支持参考50天线约62.6元。看好可留意中移购11976,行使价73.55元,20年3月到期。或中移牛52600,收回价58.28元,行使价57.08元,20年4月到期。

手机设备股舜宇光学(2382)周一低位曾失守135元,观望反弹,看好可留意舜光购12949,行使价166.68元,20年5月到期。或舜光牛64276,收回价124.88元,行使价120.88元,20年11月到期。相反看淡可留意舜光沽12814,行使价119.88元,20年5月到期。或舜光熊64527,收回价154.88元,行使价158.88元,20年11月到期。

瑞声科技(2018)周一则升逾1%,一度重返66元以上。看好可留意瑞声购15032,行使价76.78元,20年6月到期。相反看淡可留意瑞声沽13452,行使价57.88元,20年7月到期。

医药股续向上,石药集团(1093)周一升约2%,曾重上18.6元。看好可考虑石药购11412,行使价19.82元,20年2月到期。或石药牛61638,收回价16.68元,行使价15.98元,20年6月到期。相反看淡可留意石药沽12763,行使价17.78元,20年5月到期。或石药熊61973,收回价21.08元,行使价21.78元,20年6月到期。

中国生物制药(1177)周一同样升逾2%,高位重上11元。看好可考虑中药购13876,行使价12.18元,20年6月到期。或中药牛62532,收回价9.38元,行使价8.98元,20年9月到期。相反看淡可留意中药沽24621,行使价9.08元,20年3月到期。

(本结构性产品并无抵押品)

《瑞信香港认股证及牛熊证销售主管何启聪》

免责声明:笔者为瑞士信贷(香港)有限公司的代表 ,并身为证监会持牌人,并无持有相关上市公司的任何财务权益。本文内容仅供参考,并不构成要约、建议或促使任何人士提呈买卖或认购任何证券。结构性产品价格可急升或急跌,投资者或会蒙受全盘损失。本产品并无抵押品。如发行人无力偿债或违约,投资者可能无法收回部份或全部应收款项。牛熊证备强制赎回机制而可能被提早终止,届时(i)N类牛熊证投资者将不获发任何金额;而(ii)R类牛熊证之剩余价值可能为零。有关恒生指数或恒生中国企业指数的免责声明,请参阅上市文件。过往表现并不反映将来表现。投资前,投资者应了解风险,并谘询专业顾问及查阅有关上市文件。瑞信之联属公司为结构性产品之流通量提供者,亦可能是唯一报价者。本文任何内容概不构成投资、法律、会计或税务意见、并无声明任何投资或策略适合或符合阁下的个别情况。结构性产品交投量并不是结构性产品表现的指标,投资者不应仅依赖交投量历史高位数据以厘定结构性产品日後的表现。~重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account